Mercury Laboratories Ltd

Mercury Labs Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Mercury Laboratories Ltd

₹ 821 -1.52%
30 Apr - close price
mercurylabs.com BSE: 538964
About

Incorporated in 1962, Mercury Laboratories
Ltd manufactures and exports Pharmaceutical items of gynec and pediatrics

Key Points

Product Categories:[1]
Analgesic, Anti-inflammatory, Anti-pyretic, Anthelmintic, Antibiotic, Anti-coagulant,
Anti- platelet, Bleeding agents, Anti-fungal, Anti-hypertensive drugs, Anti malarial drugs, Cardiovascular System, Central Nervous System, Eye, Gastro-intestinal system, Hypoglycemic (Anti-diabetic), Multivitamin, Protein supplement, Respiratory System, Anti- allergic, Steroids, Urinary system, Uterine stimulant, Tablets, Oral Liquids, Small Volume Parenterals, Eye/Ear Drops

Website BSE
  • Market Cap ₹ 98.6 Cr.
  • Current Price ₹ 821
  • High / Low ₹ 1,190 / 736
  • Stock P/E 25.0
  • Book Value ₹ 431
  • Dividend Yield 0.43 %
  • ROCE 13.4 %
  • ROE 11.6 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • The company has delivered a poor sales growth of 6.36% over past five years.
  • Company has a low return on equity of 11.3% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024
15.60 13.33 17.60 22.07 16.23 19.43 18.32 22.76 17.11 17.37 16.68 18.19 19.57
14.18 12.15 15.33 17.39 15.65 18.39 16.66 20.28 14.88 14.71 15.07 16.88 17.59
Operating Profit 1.42 1.18 2.27 4.68 0.58 1.04 1.66 2.48 2.23 2.66 1.61 1.31 1.98
OPM % 9.10% 8.85% 12.90% 21.21% 3.57% 5.35% 9.06% 10.90% 13.03% 15.31% 9.65% 7.20% 10.12%
0.09 0.57 0.49 0.22 0.58 0.43 0.15 0.36 0.18 0.41 0.15 0.21 0.53
Interest 0.15 0.04 0.09 0.09 0.08 0.10 0.08 0.11 0.10 0.10 0.14 0.15 0.13
Depreciation 0.62 0.62 0.61 0.62 0.63 0.62 0.68 0.71 0.72 0.72 0.70 0.71 0.74
Profit before tax 0.74 1.09 2.06 4.19 0.45 0.75 1.05 2.02 1.59 2.25 0.92 0.66 1.64
Tax % 28.38% 24.77% 28.64% 25.06% -35.56% 50.67% 5.71% 25.74% 22.01% 15.11% 63.04% 22.73% 27.44%
0.52 0.83 1.46 3.14 0.61 0.37 1.00 1.51 1.24 1.91 0.34 0.50 1.19
EPS in Rs 4.33 6.92 12.17 26.17 5.08 3.08 8.33 12.58 10.33 15.92 2.83 4.17 9.92
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
33.46 41.45 41.19 47.51 48.02 51.86 55.52 57.27 68.60 57.92 75.33 75.56 71.81
29.63 35.08 35.40 41.04 41.30 47.44 49.79 51.10 59.01 50.92 66.73 66.53 64.25
Operating Profit 3.83 6.37 5.79 6.47 6.72 4.42 5.73 6.17 9.59 7.00 8.60 9.03 7.56
OPM % 11.45% 15.37% 14.06% 13.62% 13.99% 8.52% 10.32% 10.77% 13.98% 12.09% 11.42% 11.95% 10.53%
0.72 0.79 1.12 0.78 0.35 0.42 1.04 0.85 0.88 0.94 1.69 1.09 1.30
Interest 0.41 1.47 1.12 1.13 0.89 0.91 1.09 0.82 0.64 0.45 0.36 0.38 0.52
Depreciation 0.32 0.89 1.18 1.18 1.29 1.47 1.63 1.87 1.92 2.45 2.48 2.82 2.87
Profit before tax 3.82 4.80 4.61 4.94 4.89 2.46 4.05 4.33 7.91 5.04 7.45 6.92 5.47
Tax % 33.51% 32.71% 27.98% 20.45% 44.79% 17.89% 29.88% 25.40% 32.49% 29.17% 24.97% 18.35%
2.54 3.22 3.31 3.92 2.70 2.01 2.84 3.23 5.34 3.56 5.58 5.65 3.94
EPS in Rs 21.17 26.83 27.58 32.67 22.50 16.75 23.67 26.92 44.50 29.67 46.50 47.08 32.84
Dividend Payout % 7.09% 5.59% 5.44% 4.59% 6.67% 8.96% 6.34% 7.43% 7.87% 11.80% 7.53% 7.43%
Compounded Sales Growth
10 Years: 6%
5 Years: 6%
3 Years: 3%
TTM: -7%
Compounded Profit Growth
10 Years: 6%
5 Years: 15%
3 Years: 2%
TTM: -4%
Stock Price CAGR
10 Years: 35%
5 Years: 25%
3 Years: 20%
1 Year: -6%
Return on Equity
10 Years: 12%
5 Years: 12%
3 Years: 11%
Last Year: 12%

Balance Sheet

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 1.20 1.20 1.20 1.20 1.20 1.20 1.20 1.20 1.20 1.20 1.20 1.20 1.20
Reserves 11.19 14.21 16.94 20.65 23.27 25.15 27.77 30.78 35.69 39.11 44.43 49.64 50.50
8.63 11.24 8.88 7.37 7.44 9.76 9.56 7.19 7.10 5.99 5.83 5.55 4.60
11.86 13.56 15.50 17.30 19.23 15.59 18.76 17.13 21.38 16.14 12.70 11.57 13.13
Total Liabilities 32.88 40.21 42.52 46.52 51.14 51.70 57.29 56.30 65.37 62.44 64.16 67.96 69.43
17.89 19.48 19.48 18.57 18.39 20.78 24.39 23.66 26.36 25.82 24.26 24.03 24.92
CWIP 0.00 0.00 0.00 0.00 0.40 0.24 0.00 0.00 0.00 0.00 0.13 3.82 7.51
Investments 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01
14.98 20.72 23.03 27.94 32.34 30.67 32.89 32.63 39.00 36.61 39.76 40.10 36.99
Total Assets 32.88 40.21 42.52 46.52 51.14 51.70 57.29 56.30 65.37 62.44 64.16 67.96 69.43

Cash Flows

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
6.95 3.47 3.49 -0.10 1.92 4.97 5.22 5.49 8.21 5.19 2.45 8.23
-11.63 -2.48 -1.54 -0.28 -1.50 -3.68 -4.99 -1.14 -4.62 -1.89 -1.06 -6.27
5.20 -1.04 -2.12 0.47 -0.25 1.07 -2.54 -3.33 -1.24 -1.23 -1.01 -1.04
Net Cash Flow 0.52 -0.05 -0.18 0.09 0.17 2.36 -2.31 1.02 2.36 2.07 0.38 0.91

Ratios

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 67.31 104.70 107.84 103.02 133.25 103.60 126.82 115.61 119.93 105.49 103.55 105.55
Inventory Days 89.52 72.20 93.92 115.50 137.30 119.80 93.95 78.44 60.42 104.59 82.82 74.81
Days Payable 152.83 135.37 159.39 136.34 186.56 138.65 161.71 120.01 137.94 105.98 76.58 62.40
Cash Conversion Cycle 4.00 41.53 42.37 82.19 83.99 84.75 59.05 74.04 42.41 104.10 109.79 117.96
Working Capital Days 29.34 33.90 44.22 75.52 102.84 90.58 88.75 88.78 75.02 98.50 103.35 102.94
ROCE % 24.64% 25.68% 21.35% 21.59% 18.91% 9.82% 13.77% 13.26% 20.56% 11.83% 16.04% 13.41%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
73.66% 73.66% 73.66% 73.66% 73.66% 73.66% 73.66% 73.66% 73.66% 73.66% 73.66% 73.66%
26.34% 26.35% 26.34% 26.35% 26.35% 26.34% 26.35% 26.34% 26.35% 26.36% 26.34% 26.34%
No. of Shareholders 1,1821,1851,1871,1461,1191,1491,1611,2141,2591,3451,4111,397

Documents

Announcements

Annual reports

Credit ratings